Official conference page for 2026 Seattle Cellular Therapy Summit.

About 2026 Seattle Cellular Therapy Summit

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

Ryan Cassaday
Paolo Strati
27+

Conference program and agenda

Our Agenda

Day 1: Friday, August 14th, 2026

All timings are in Pacific Time (PDT, GMT-07:00) time.

08:00 AM - 09:15 AMRegistration, Breakfast, & Exhibits
09:15 AM - 09:30 AMWelcome & Opening Remarks
09:30 AM - 09:45 AMBinaytara's Efforts in Improving Cancer Care Disparities
09:45 AM - 11:15 AMSolid Tumors I

Session Chair: Lawrence Fong, MD

09:45 AM - 10:00 AM

Immuno-oncology for GU Malignancies Lawrence Fong, MD

10:00 AM - 10:15 AM

Lung Cancer: Tarlatamab Sid Devarakonda, MD

10:15 AM - 10:30 AM

Malignant Melanoma: Lifileucel and Beyond Max Julve

10:30 AM - 10:45 AM

Immunotherapy for Sarcoma Lara Davis, MD

10:45 AM - 11:15 AM

Panel Discussion

Moderators:

Lawrence Fong, MD

Panelists:

Sid Devarakonda, MD; Max Julve ; Lara Davis, MD

11:15 AM - 12:15 PMSolid Tumors II

Session Chair: Folashade Otegbeye, MBBCh, MPH

11:15 AM - 11:30 AM

Novel FOLR1 CAR-T Therapy Soheil Meshinchi

11:30 AM - 11:45 AM

FACT Standards for Immune Effector Cells in the Community Setting Folashade Otegbeye, MBBCh, MPH

11:45 AM - 12:15 PM

Panel Discussion

Moderators:

Folashade Otegbeye, MBBCh, MPH

Panelists:

Soheil Meshinchi

12:15 PM - 01:15 PMLunch & Exhibits
01:15 PM - 02:30 PMCAR-T Cells — The Next Breakthroughs

Session Chair: Natalie Wuliji, DO

01:15 PM - 01:30 PM

Multispecific CAR-T — Will They Change Our Standard of Care? Saurabh Dahiya, MD

01:30 PM - 01:45 PM

In-Vivo CAR-T Platforms Hans-Peter Kiem, PhD

01:45 PM - 02:00 PM

CAR-T Therapy for Autoimmune Disorders Natalie Wuliji, DO

02:00 PM - 02:30 PM

Panel Discussion

Moderators:

Natalie Wuliji, DO

Panelists:

Saurabh Dahiya, MD; Hans-Peter Kiem, PhD

02:30 PM - 02:45 PMBreak & Exhibits
02:45 PM - 03:45 PMLeukemia and Transplant

Session Chair: Filippo Milano, MD

02:45 PM - 03:00 PM

Immunotherapy for Myeloid Malignancies — Challenges and Promises Hany Elmariah

03:00 PM - 03:15 PM

Cellular Therapy in Allogeneic Transplant (Orca-T, Omidubicel and Beyond) Filippo Milano, MD

03:15 PM - 03:30 PM

ALL — Focus on Immunotherapeutic Approaches, Approved and Investigational Options Ryan Cassaday, MD

03:30 PM - 03:45 PM

Panel Discussion

Moderators:

Filippo Milano, MD

Panelists:

Hany Elmariah ; Ryan Cassaday, MD

03:45 PM - 04:45 PMChronic Lymphocytic Leukemia

Session Chair: Alexey Danilov, MD

03:45 PM - 04:00 PM

Immunotherapy (CAR-T and Bispecific Antibodies) for CLL Bita Fakhri, MD, MPH

04:00 PM - 04:15 PM

How Will CLL Be Treated in 2030? Alexey Danilov, MD

04:15 PM - 04:45 PM

Panel Discussion

Moderators:

Alexey Danilov, MD

Panelists:

Bita Fakhri, MD, MPH

Day 2: Saturday, August 15th, 2026

07:00 AM - 08:00 AMRegistration, Breakfast, & Exhibits
08:00 AM - 09:30 AMTopics in T-Cell Engaging Therapies

Session Chair: Mazyar Shadman, MD

08:00 AM - 08:15 AM

Barriers to CAR-T Use — Challenges and Opportunities Mazyar Shadman, MD

08:15 AM - 08:30 AM

Bispecific Antibodies in Community Setting — General Principles Sibel Blau, MD

08:30 AM - 08:45 AM

Next-Generation T-Cell Engagers

08:45 AM - 09:00 AM

State of Cellular Immunotherapy in 2030 Matthew Alexander Lunning, DO

09:00 AM - 09:30 AM

Panel Discussion

Moderators:

Mazyar Shadman, MD

Panelists:

Sibel Blau, MD; Krish Patel ; Matthew Alexander Lunning, DO

Venue and map

Accreditations and continuing education

Accreditation

Registration and pricing

Exhibitors and sponsorship